NDC 43825-200 – Terlivaz
Terlipressin .85 mg/5mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC43825-200
Product details
- Brand name
- Terlivaz
- Generic name
- Terlipressin
- Labeler
- Mallinckrodt Hospital Products Inc.
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- NDA · NDA022231
- Marketed since
- September 14, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- Vasopressin Receptor Agonist
Active ingredients
- Terlipressin .85 mg/5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 43825-200-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (43825-200-01) / 5 mL in 1 VIAL, SINGLE-DOSE | Sep 14, 2022 |
Recalls mentioning this NDC
- D-0341-2024 Feb 28, 2024 · Class II
cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.